Industry Research Reports
Home > Reports > Service & Software > Global Next-Generation Sequencing eDNA Biomonitoring Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Next-Generation Sequencing eDNA Biomonitoring Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-05
Pages: 145 Pages
Report ld: 4850865
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Next-Generation Sequencing eDNA Biomonitoring Market Size(US$)
CAGR 2025-2031
8.1%
Market Size,2031
USD 40.7
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 25.5 million
Market Forecast in 2031(Value)
US$ 40.7 million
CAGR
8.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Next-Generation Sequencing eDNA Biomonitoring market is projected to grow from US$ 23.8 million in 2024 to US$ 40.7 million by 2031, at a CAGR of 8.1% (2025-2031), driven by critical product segments and diverse end‑use applications.
Next-generation sequencing technology, also known as high-throughput sequencing technology or new generation sequencing technology, can split DNA samples into thousands of tiny fragments, and quickly read them through high-throughput sequencers, and finally splice out a complete DNA sequence. This technology has the advantages of high throughput, low cost and short sequencing cycle, and shows extremely high detection accuracy and sensitivity in genome sequencing and genome monitoring.
High-throughput sequencing technology (i.e., next-generation sequencing technology) has the advantages of high throughput, low cost, and short sequencing cycle, and shows extremely high detection accuracy and sensitivity in genome sequencing and genome monitoring. These technological advances have made DNA biomonitoring more efficient and accurate, thereby driving the growth of the market. On the other hand, with the development of bioinformatics, the ability to analyze and interpret sequencing data is also constantly improving. This helps to extract valuable information from massive sequencing data and provide more accurate data support for environmental monitoring, disease diagnosis, etc.
With the continuous improvement of people's awareness of environmental protection, the demand for monitoring environmental DNA (eDNA) is also increasing. By monitoring DNA in the environment, we can understand the health of the ecosystem and promptly detect and respond to potential ecological problems. In the medical field, DNA sequencing technology is also widely used in disease diagnosis and prevention. By sequencing and analyzing individual genomes, the risk of individual illness can be predicted, providing strong support for early prevention and treatment of diseases. This demand has also driven the development of the next-generation sequencing environmental DNA biomonitoring market.
Although next-generation sequencing technology has made significant progress, there are still some technical challenges and limitations. For example, the accuracy and sensitivity of sequencing need to be further improved to better meet the needs of environmental monitoring and disease diagnosis. The amount of data generated by sequencing is huge, and contains a lot of redundant and erroneous information. How to extract valuable information from massive data is a technical problem currently faced. In addition, data analysis also requires professional knowledge and skills, which increases the complexity and cost of the operation.
In addition, although the cost of next-generation sequencing technology has been greatly reduced, it is still a considerable expense for some small laboratories or research institutions. The high cost of sequencing limits the widespread application and promotion of the technology.
Although the next-generation sequencing environmental DNA biomonitoring technology has broad application prospects, the current market awareness of it is not high. Some potential customers may take a wait-and-see attitude towards this new technology, waiting for it to further mature and popularize. Customers in different fields and industries have different acceptance of technology. Some fields may prefer to adopt traditional monitoring methods and technologies, and are less willing to try new sequencing technologies.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Next-Generation Sequencing eDNA Biomonitoring market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Illumina, Inc
- Stantec
- Eurofins Genomics
- Spygen
- ID-Gene Ecordiagnostics
- EnviroDNA
- eDNAtec
- Genidaqs
- NatureMetrics
- Jonah Ventures
- Sinsoma GmbH
- SimplexDNA
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Targeted Sequencing & Resequencing
- Whole Genome Sequencing
- Whole Exome Sequencing
Segment by Application
- Water
- Soil
- Air
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Next-Generation Sequencing eDNA Biomonitoring study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Next-Generation Sequencing eDNA Biomonitoring: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Next-Generation Sequencing eDNA Biomonitoring Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Targeted Sequencing & Resequencing
1.2.3 Whole Genome Sequencing
1.2.4 Whole Exome Sequencing
1.3 Market Segmentation by Application
1.3.1 Global Next-Generation Sequencing eDNA Biomonitoring Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Water
1.3.3 Soil
1.3.4 Air
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Next-Generation Sequencing eDNA Biomonitoring Revenue Estimates and Forecasts 2020-2031
2.2 Global Next-Generation Sequencing eDNA Biomonitoring Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Next-Generation Sequencing eDNA Biomonitoring Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Next-Generation Sequencing eDNA Biomonitoring Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Targeted Sequencing & Resequencing Market Size by Players
3.3.2 Whole Genome Sequencing Market Size by Players
3.3.3 Whole Exome Sequencing Market Size by Players
3.4 Global Next-Generation Sequencing eDNA Biomonitoring Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Next-Generation Sequencing eDNA Biomonitoring Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Next-Generation Sequencing eDNA Biomonitoring Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Next-Generation Sequencing eDNA Biomonitoring Market Size by Type (2020-2031)
6.4 North America Next-Generation Sequencing eDNA Biomonitoring Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Next-Generation Sequencing eDNA Biomonitoring Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Next-Generation Sequencing eDNA Biomonitoring Market Size by Type (2020-2031)
7.4 Europe Next-Generation Sequencing eDNA Biomonitoring Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Next-Generation Sequencing eDNA Biomonitoring Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Next-Generation Sequencing eDNA Biomonitoring Market Size by Type (2020-2031)
8.4 Asia-Pacific Next-Generation Sequencing eDNA Biomonitoring Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Next-Generation Sequencing eDNA Biomonitoring Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Next-Generation Sequencing eDNA Biomonitoring Market Size by Type (2020-2031)
9.4 Central and South America Next-Generation Sequencing eDNA Biomonitoring Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Next-Generation Sequencing eDNA Biomonitoring Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Next-Generation Sequencing eDNA Biomonitoring Market Size by Type (2020-2031)
10.4 Middle East and Africa Next-Generation Sequencing eDNA Biomonitoring Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Next-Generation Sequencing eDNA Biomonitoring Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Illumina, Inc
11.1.1 Illumina, Inc Corporation Information
11.1.2 Illumina, Inc Business Overview
11.1.3 Illumina, Inc Next-Generation Sequencing eDNA Biomonitoring Product Features and Attributes
11.1.4 Illumina, Inc Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2020-2025)
11.1.5 Illumina, Inc Next-Generation Sequencing eDNA Biomonitoring Revenue by Product in 2024
11.1.6 Illumina, Inc Next-Generation Sequencing eDNA Biomonitoring Revenue by Application in 2024
11.1.7 Illumina, Inc Next-Generation Sequencing eDNA Biomonitoring Revenue by Geographic Area in 2024
11.1.8 Illumina, Inc Next-Generation Sequencing eDNA Biomonitoring SWOT Analysis
11.1.9 Illumina, Inc Recent Developments
11.2 Stantec
11.2.1 Stantec Corporation Information
11.2.2 Stantec Business Overview
11.2.3 Stantec Next-Generation Sequencing eDNA Biomonitoring Product Features and Attributes
11.2.4 Stantec Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2020-2025)
11.2.5 Stantec Next-Generation Sequencing eDNA Biomonitoring Revenue by Product in 2024
11.2.6 Stantec Next-Generation Sequencing eDNA Biomonitoring Revenue by Application in 2024
11.2.7 Stantec Next-Generation Sequencing eDNA Biomonitoring Revenue by Geographic Area in 2024
11.2.8 Stantec Next-Generation Sequencing eDNA Biomonitoring SWOT Analysis
11.2.9 Stantec Recent Developments
11.3 Eurofins Genomics
11.3.1 Eurofins Genomics Corporation Information
11.3.2 Eurofins Genomics Business Overview
11.3.3 Eurofins Genomics Next-Generation Sequencing eDNA Biomonitoring Product Features and Attributes
11.3.4 Eurofins Genomics Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2020-2025)
11.3.5 Eurofins Genomics Next-Generation Sequencing eDNA Biomonitoring Revenue by Product in 2024
11.3.6 Eurofins Genomics Next-Generation Sequencing eDNA Biomonitoring Revenue by Application in 2024
11.3.7 Eurofins Genomics Next-Generation Sequencing eDNA Biomonitoring Revenue by Geographic Area in 2024
11.3.8 Eurofins Genomics Next-Generation Sequencing eDNA Biomonitoring SWOT Analysis
11.3.9 Eurofins Genomics Recent Developments
11.4 Spygen
11.4.1 Spygen Corporation Information
11.4.2 Spygen Business Overview
11.4.3 Spygen Next-Generation Sequencing eDNA Biomonitoring Product Features and Attributes
11.4.4 Spygen Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2020-2025)
11.4.5 Spygen Next-Generation Sequencing eDNA Biomonitoring Revenue by Product in 2024
11.4.6 Spygen Next-Generation Sequencing eDNA Biomonitoring Revenue by Application in 2024
11.4.7 Spygen Next-Generation Sequencing eDNA Biomonitoring Revenue by Geographic Area in 2024
11.4.8 Spygen Next-Generation Sequencing eDNA Biomonitoring SWOT Analysis
11.4.9 Spygen Recent Developments
11.5 ID-Gene Ecordiagnostics
11.5.1 ID-Gene Ecordiagnostics Corporation Information
11.5.2 ID-Gene Ecordiagnostics Business Overview
11.5.3 ID-Gene Ecordiagnostics Next-Generation Sequencing eDNA Biomonitoring Product Features and Attributes
11.5.4 ID-Gene Ecordiagnostics Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2020-2025)
11.5.5 ID-Gene Ecordiagnostics Next-Generation Sequencing eDNA Biomonitoring Revenue by Product in 2024
11.5.6 ID-Gene Ecordiagnostics Next-Generation Sequencing eDNA Biomonitoring Revenue by Application in 2024
11.5.7 ID-Gene Ecordiagnostics Next-Generation Sequencing eDNA Biomonitoring Revenue by Geographic Area in 2024
11.5.8 ID-Gene Ecordiagnostics Next-Generation Sequencing eDNA Biomonitoring SWOT Analysis
11.5.9 ID-Gene Ecordiagnostics Recent Developments
11.6 EnviroDNA
11.6.1 EnviroDNA Corporation Information
11.6.2 EnviroDNA Business Overview
11.6.3 EnviroDNA Next-Generation Sequencing eDNA Biomonitoring Product Features and Attributes
11.6.4 EnviroDNA Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2020-2025)
11.6.5 EnviroDNA Recent Developments
11.7 eDNAtec
11.7.1 eDNAtec Corporation Information
11.7.2 eDNAtec Business Overview
11.7.3 eDNAtec Next-Generation Sequencing eDNA Biomonitoring Product Features and Attributes
11.7.4 eDNAtec Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2020-2025)
11.7.5 eDNAtec Recent Developments
11.8 Genidaqs
11.8.1 Genidaqs Corporation Information
11.8.2 Genidaqs Business Overview
11.8.3 Genidaqs Next-Generation Sequencing eDNA Biomonitoring Product Features and Attributes
11.8.4 Genidaqs Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2020-2025)
11.8.5 Genidaqs Recent Developments
11.9 NatureMetrics
11.9.1 NatureMetrics Corporation Information
11.9.2 NatureMetrics Business Overview
11.9.3 NatureMetrics Next-Generation Sequencing eDNA Biomonitoring Product Features and Attributes
11.9.4 NatureMetrics Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2020-2025)
11.9.5 NatureMetrics Recent Developments
11.10 Jonah Ventures
11.10.1 Jonah Ventures Corporation Information
11.10.2 Jonah Ventures Business Overview
11.10.3 Jonah Ventures Next-Generation Sequencing eDNA Biomonitoring Product Features and Attributes
11.10.4 Jonah Ventures Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Sinsoma GmbH
11.11.1 Sinsoma GmbH Corporation Information
11.11.2 Sinsoma GmbH Business Overview
11.11.3 Sinsoma GmbH Next-Generation Sequencing eDNA Biomonitoring Product Features and Attributes
11.11.4 Sinsoma GmbH Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2020-2025)
11.11.5 Sinsoma GmbH Recent Developments
11.12 SimplexDNA
11.12.1 SimplexDNA Corporation Information
11.12.2 SimplexDNA Business Overview
11.12.3 SimplexDNA Next-Generation Sequencing eDNA Biomonitoring Product Features and Attributes
11.12.4 SimplexDNA Next-Generation Sequencing eDNA Biomonitoring Revenue and Gross Margin (2020-2025)
11.12.5 SimplexDNA Recent Developments
12 Next-Generation Sequencing eDNA BiomonitoringIndustry Chain Analysis
12.1 Next-Generation Sequencing eDNA Biomonitoring Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Next-Generation Sequencing eDNA Biomonitoring Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Next-Generation Sequencing eDNA Biomonitoring Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Next-Generation Sequencing eDNA Biomonitoring Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Next-Generation Sequencing eDNA Biomonitoring Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Next-Generation Sequencing eDNA Biomonitoring Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Next-Generation Sequencing eDNA Biomonitoring Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Next-Generation Sequencing eDNA Biomonitoring Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Next-Generation Sequencing eDNA Biomonitoring Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Next-Generation Sequencing eDNA Biomonitoring Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Next-Generation Sequencing eDNA Biomonitoring by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Sequencing eDNA Biomonitoring as of 2024)
Table 11. Global Next-Generation Sequencing eDNA Biomonitoring Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Next-Generation Sequencing eDNA Biomonitoring Companies Headquarters
Table 13. Global Next-Generation Sequencing eDNA Biomonitoring Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Next-Generation Sequencing eDNA Biomonitoring Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Next-Generation Sequencing eDNA Biomonitoring Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Next-Generation Sequencing eDNA Biomonitoring Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Next-Generation Sequencing eDNA Biomonitoring Revenue by Application (2026-2031) & (US$ Million)
Table 21. Next-Generation Sequencing eDNA Biomonitoring High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Next-Generation Sequencing eDNA Biomonitoring Growth Accelerators and Market Barriers
Table 25. North America Next-Generation Sequencing eDNA Biomonitoring Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Next-Generation Sequencing eDNA Biomonitoring Growth Accelerators and Market Barriers
Table 27. Europe Next-Generation Sequencing eDNA Biomonitoring Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Next-Generation Sequencing eDNA Biomonitoring Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Next-Generation Sequencing eDNA Biomonitoring Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Next-Generation Sequencing eDNA Biomonitoring Investment Opportunities and Key Challenges
Table 31. Central and South America Next-Generation Sequencing eDNA Biomonitoring Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Next-Generation Sequencing eDNA Biomonitoring Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Next-Generation Sequencing eDNA Biomonitoring Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Illumina, Inc Corporation Information
Table 35. Illumina, Inc Description and Major Businesses
Table 36. Illumina, Inc Product Features and Attributes
Table 37. Illumina, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Illumina, Inc Revenue Proportion by Product in 2024
Table 39. Illumina, Inc Revenue Proportion by Application in 2024
Table 40. Illumina, Inc Revenue Proportion by Geographic Area in 2024
Table 41. Illumina, Inc Next-Generation Sequencing eDNA Biomonitoring SWOT Analysis
Table 42. Illumina, Inc Recent Developments
Table 43. Stantec Corporation Information
Table 44. Stantec Description and Major Businesses
Table 45. Stantec Product Features and Attributes
Table 46. Stantec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Stantec Revenue Proportion by Product in 2024
Table 48. Stantec Revenue Proportion by Application in 2024
Table 49. Stantec Revenue Proportion by Geographic Area in 2024
Table 50. Stantec Next-Generation Sequencing eDNA Biomonitoring SWOT Analysis
Table 51. Stantec Recent Developments
Table 52. Eurofins Genomics Corporation Information
Table 53. Eurofins Genomics Description and Major Businesses
Table 54. Eurofins Genomics Product Features and Attributes
Table 55. Eurofins Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Eurofins Genomics Revenue Proportion by Product in 2024
Table 57. Eurofins Genomics Revenue Proportion by Application in 2024
Table 58. Eurofins Genomics Revenue Proportion by Geographic Area in 2024
Table 59. Eurofins Genomics Next-Generation Sequencing eDNA Biomonitoring SWOT Analysis
Table 60. Eurofins Genomics Recent Developments
Table 61. Spygen Corporation Information
Table 62. Spygen Description and Major Businesses
Table 63. Spygen Product Features and Attributes
Table 64. Spygen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Spygen Revenue Proportion by Product in 2024
Table 66. Spygen Revenue Proportion by Application in 2024
Table 67. Spygen Revenue Proportion by Geographic Area in 2024
Table 68. Spygen Next-Generation Sequencing eDNA Biomonitoring SWOT Analysis
Table 69. Spygen Recent Developments
Table 70. ID-Gene Ecordiagnostics Corporation Information
Table 71. ID-Gene Ecordiagnostics Description and Major Businesses
Table 72. ID-Gene Ecordiagnostics Product Features and Attributes
Table 73. ID-Gene Ecordiagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. ID-Gene Ecordiagnostics Revenue Proportion by Product in 2024
Table 75. ID-Gene Ecordiagnostics Revenue Proportion by Application in 2024
Table 76. ID-Gene Ecordiagnostics Revenue Proportion by Geographic Area in 2024
Table 77. ID-Gene Ecordiagnostics Next-Generation Sequencing eDNA Biomonitoring SWOT Analysis
Table 78. ID-Gene Ecordiagnostics Recent Developments
Table 79. EnviroDNA Corporation Information
Table 80. EnviroDNA Description and Major Businesses
Table 81. EnviroDNA Product Features and Attributes
Table 82. EnviroDNA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. EnviroDNA Recent Developments
Table 84. eDNAtec Corporation Information
Table 85. eDNAtec Description and Major Businesses
Table 86. eDNAtec Product Features and Attributes
Table 87. eDNAtec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. eDNAtec Recent Developments
Table 89. Genidaqs Corporation Information
Table 90. Genidaqs Description and Major Businesses
Table 91. Genidaqs Product Features and Attributes
Table 92. Genidaqs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Genidaqs Recent Developments
Table 94. NatureMetrics Corporation Information
Table 95. NatureMetrics Description and Major Businesses
Table 96. NatureMetrics Product Features and Attributes
Table 97. NatureMetrics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. NatureMetrics Recent Developments
Table 99. Jonah Ventures Corporation Information
Table 100. Jonah Ventures Description and Major Businesses
Table 101. Jonah Ventures Product Features and Attributes
Table 102. Jonah Ventures Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Jonah Ventures Recent Developments
Table 104. Sinsoma GmbH Corporation Information
Table 105. Sinsoma GmbH Description and Major Businesses
Table 106. Sinsoma GmbH Product Features and Attributes
Table 107. Sinsoma GmbH Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Sinsoma GmbH Recent Developments
Table 109. SimplexDNA Corporation Information
Table 110. SimplexDNA Description and Major Businesses
Table 111. SimplexDNA Product Features and Attributes
Table 112. SimplexDNA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. SimplexDNA Recent Developments
Table 114. Raw Materials Key Suppliers
Table 115. Distributors List
Table 116. Market Trends and Market Evolution
Table 117. Market Drivers and Opportunities
Table 118. Market Challenges, Risks, and Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Next-Generation Sequencing eDNA Biomonitoring Product Picture
Figure 2. Global Next-Generation Sequencing eDNA Biomonitoring Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Targeted Sequencing & Resequencing Product Picture
Figure 4. Whole Genome Sequencing Product Picture
Figure 5. Whole Exome Sequencing Product Picture
Figure 6. Global Next-Generation Sequencing eDNA Biomonitoring Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Water
Figure 8. Soil
Figure 9. Air
Figure 10. Others
Figure 11. Next-Generation Sequencing eDNA Biomonitoring Report Years Considered
Figure 12. Global Next-Generation Sequencing eDNA Biomonitoring Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 14. Global Next-Generation Sequencing eDNA Biomonitoring Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Next-Generation Sequencing eDNA Biomonitoring Revenue Market Share by Region (2020-2031)
Figure 16. Global Next-Generation Sequencing eDNA Biomonitoring Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Targeted Sequencing & Resequencing Revenue Market Share by Player in 2024
Figure 19. Whole Genome Sequencing Revenue Market Share by Player in 2024
Figure 20. Whole Exome Sequencing Revenue Market Share by Player in 2024
Figure 21. Global Next-Generation Sequencing eDNA Biomonitoring Revenue Market Share by Type (2020-2031)
Figure 22. Global Next-Generation Sequencing eDNA Biomonitoring Revenue Market Share by Application (2020-2031)
Figure 23. North America Next-Generation Sequencing eDNA Biomonitoring Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) in 2024
Figure 25. North America Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) by Application (2020-2031)
Figure 27. US Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 28. Canada Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 30. Europe Next-Generation Sequencing eDNA Biomonitoring Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) in 2024
Figure 32. Europe Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 35. France Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 37. Italy Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 38. Russia Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Next-Generation Sequencing eDNA Biomonitoring Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 44. Japan Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 46. Australia Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 47. India Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America Next-Generation Sequencing eDNA Biomonitoring Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) in 2024
Figure 55. Central and South America Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa Next-Generation Sequencing eDNA Biomonitoring Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) in 2024
Figure 61. South America Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa Next-Generation Sequencing eDNA Biomonitoring Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2025) & (US$ Million)
Figure 64. Israel Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa Next-Generation Sequencing eDNA Biomonitoring Revenue (2020-2025) & (US$ Million)
Figure 67. Next-Generation Sequencing eDNA Biomonitoring Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Next-Generation Sequencing eDNA Biomonitoring in 2031?
The global market size of Next-Generation Sequencing eDNA Biomonitoring in 2031 was 40.7 Million USD.
Which region is expected to have the highest market share?
What was the global market size of Next-Generation Sequencing eDNA Biomonitoring in 2025?
What is the annual compound growth rate of the global Next-Generation Sequencing eDNA Biomonitoring market size from 2025 to 2031?
Which companies rank high in the global Next-Generation Sequencing eDNA Biomonitoring market?
Related Reports
Global Next-Generation Sequencing eDNA Biomonitoring Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Next-Generation Sequencing eDNA Biomonitoring market is projected to grow from US$ 25.54 million in 2025 to US$ 43.72 million by 2032, at a CAGR of 8.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 139
USD 4900.00
(Single User License)
Global Next-Generation Sequencing eDNA Biomonitoring Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Next-Generation Sequencing eDNA Biomonitoring market size was US$ 25.54 million in 2025 and is forecast to reach a readjusted size of US$ 43.72 million by 2032 with a CAGR of 8.1% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 94
USD 4250.00
(Single User License)
Next-Generation Sequencing eDNA Biomonitoring - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Next-Generation Sequencing eDNA Biomonitoring was estimated to be worth US$ 25.54 million in 2025 and is projected to reach US$ 43.72 million, growing at a CAGR of 8.1% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 106
USD 3950.00
(Single User License)
Global Next-Generation Sequencing eDNA Biomonitoring Market Research Report 2026
The global Next-Generation Sequencing eDNA Biomonitoring market was valued at US$ 25.54 million in 2025 and is anticipated to reach US$ 43.72 million by 2032, at a CAGR of 8.1% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 112
USD 2900.00
(Single User License)
Global Next-Generation Sequencing eDNA Biomonitoring Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Next-Generation Sequencing eDNA Biomonitoring market size was US$ 23.8 million in 2024 and is forecast to a readjusted size of US$ 40.7 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 98
USD 4250.00
(Single User License)
Next-Generation Sequencing eDNA Biomonitoring - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Next-Generation Sequencing eDNA Biomonitoring was estimated to be worth US$ 23.8 million in 2024 and is forecast to a readjusted size of US$ 40.7 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 117
USD 3950.00
(Single User License)
Global Next-Generation Sequencing eDNA Biomonitoring Market Research Report 2025
The global market for Next-Generation Sequencing eDNA Biomonitoring was valued at US$ 23.8 million in the year 2024 and is projected to reach a revised size of US$ 40.7 million by 2031, growing at a CAGR of 8.1% during the forecast period.
Published Date: 2025-03-12
Pages: 90
USD 2900.00
(Single User License)
Global Next-Generation Sequencing eDNA Biomonitoring Market Research Report 2024
The global market for Next-Generation Sequencing eDNA Biomonitoring was valued at US$ 22.6 million in the year 2023 and is projected to reach a revised size of US$ 38 million by 2030, growing at a CAGR of 8.1% during the forecast period.
Published Date: 2025-01-01
Pages: 89
USD 2900.00
(Single User License)
Global and United States Next-Generation Sequencing eDNA Biomonitoring Market Report & Forecast 2024-2030
The global Next-Generation Sequencing eDNA Biomonitoring revenue was US$ 22.6 million in 2023 and is forecast to a readjusted size of US$ 38 million by 2030 with a CAGR of 8.1% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 112
USD 4350.00
(Single User License)
Global Next-Generation Sequencing eDNA Biomonitoring Market Insights, Forecast to 2030
Valued at US$ 23.8 million in 2024, the global Next-Generation Sequencing eDNA Biomonitoring market is forecast to reach US$ 38 million by 2030, at a CAGR of 8.1% during the forecast period.
Published Date: 2025-01-01
Pages: 139
USD 4900.00
(Single User License)
Global Next-Generation Sequencing eDNA Biomonitoring Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Next-Generation Sequencing eDNA Biomonitoring market is projected to grow from US$ 25.54 million in 2025 to US$ 43.72 million by 2032, at a CAGR of 8.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 139
USD 4900.00 (Single User License)Global Next-Generation Sequencing eDNA Biomonitoring Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Next-Generation Sequencing eDNA Biomonitoring market size was US$ 25.54 million in 2025 and is forecast to reach a readjusted size of US$ 43.72 million by 2032 with a CAGR of 8.1% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 94
USD 4250.00 (Single User License)Next-Generation Sequencing eDNA Biomonitoring - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Next-Generation Sequencing eDNA Biomonitoring was estimated to be worth US$ 25.54 million in 2025 and is projected to reach US$ 43.72 million, growing at a CAGR of 8.1% from 2026 to 2032.
Published: 2026-01-08
Pages: 106
USD 3950.00 (Single User License)Global Next-Generation Sequencing eDNA Biomonitoring Market Research Report 2026
The global Next-Generation Sequencing eDNA Biomonitoring market was valued at US$ 25.54 million in 2025 and is anticipated to reach US$ 43.72 million by 2032, at a CAGR of 8.1% from 2026 to 2032.
Published: 2026-01-08
Pages: 112
USD 2900.00 (Single User License)Global Next-Generation Sequencing eDNA Biomonitoring Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Next-Generation Sequencing eDNA Biomonitoring market size was US$ 23.8 million in 2024 and is forecast to a readjusted size of US$ 40.7 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 98
USD 4250.00 (Single User License)Next-Generation Sequencing eDNA Biomonitoring - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Next-Generation Sequencing eDNA Biomonitoring was estimated to be worth US$ 23.8 million in 2024 and is forecast to a readjusted size of US$ 40.7 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 117
USD 3950.00 (Single User License)Global Next-Generation Sequencing eDNA Biomonitoring Market Research Report 2025
The global market for Next-Generation Sequencing eDNA Biomonitoring was valued at US$ 23.8 million in the year 2024 and is projected to reach a revised size of US$ 40.7 million by 2031, growing at a CAGR of 8.1% during the forecast period.
Published: 2025-03-12
Pages: 90
USD 2900.00 (Single User License)Global Next-Generation Sequencing eDNA Biomonitoring Market Research Report 2024
The global market for Next-Generation Sequencing eDNA Biomonitoring was valued at US$ 22.6 million in the year 2023 and is projected to reach a revised size of US$ 38 million by 2030, growing at a CAGR of 8.1% during the forecast period.
Published: 2025-01-01
Pages: 89
USD 2900.00 (Single User License)Global and United States Next-Generation Sequencing eDNA Biomonitoring Market Report & Forecast 2024-2030
The global Next-Generation Sequencing eDNA Biomonitoring revenue was US$ 22.6 million in 2023 and is forecast to a readjusted size of US$ 38 million by 2030 with a CAGR of 8.1% during the review period (2024-2030).
Published: 2025-01-01
Pages: 112
USD 4350.00 (Single User License)Global Next-Generation Sequencing eDNA Biomonitoring Market Insights, Forecast to 2030
Valued at US$ 23.8 million in 2024, the global Next-Generation Sequencing eDNA Biomonitoring market is forecast to reach US$ 38 million by 2030, at a CAGR of 8.1% during the forecast period.
Published: 2025-01-01
Pages: 139
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now